// App-Quantinova.ai

TCT-664 : Twelve-Month Clinical Outcomes Comparing Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Coronary Stents in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Randomized Trial

Researchers

Presenter

  • Alexandre Abizaid

Principal Investigators

  • Ricardo Costa

  • Roberto Botelho

  • Pedro A. Lemos

  • Elvin Kedhi

  • Jacques J. Koolen

  • Alexander Ijsselmuiden

  • Luc Janssens

  • Farzin Fath-Ordoubadi

  • Suneel Talwar

  • Monica Masotti

  • Andrejs Erglis

  • Sasko Kedev

  • Ota Hlinomaz

  • Petr Kala

  • Krzysztof Milewski

  • Sripal Bangalore

Medical Centers

  • Albert Schweitzer Hospital, Dordrecht, Netherlands

  • Catharina hospital, Eindhoven, Netherlands

  • ICRC, St Anne University Hospital, Brno, Czech Republic

  • University Hospitals, Leuven, Belgium

  • Isala Klinieken Zwolle, Zwolle, Netherlands

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • Instituto do Coração (InCor) - Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, São Paulo, Brazil

  • Royal Bournemouth Hospital, Bournemouth, United Kingdom

  • Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia

  • New York University School of Medicine, New York, New York, United States

  • Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo, Brazil

  • University Clinic of Cardiology, Skopje, Macedonia, the former Yugoslav Republic of

  • University Hospital and Medical Faculty Masaryk University, Brno, Czech Republic

  • Center of Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland

  • Triangulo Heart Institute, Uberlândia, Minas Gerais, Brazil

Locations

  • Netherlands

  • Czech Republic

  • United Kingdom

  • United States

  • Macedonia

  • Poland

  • Belgium

  • Spain

  • Brazil

  • Latvia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Coronary artery lesions

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02112981

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved